Reviva Pharmaceuticals Holdings, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.38 | -$0.38 | -$0.38 |
| Q2 2024 | 1 | -$0.30 | -$0.30 | -$0.30 |
| Q3 2024 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q4 2024 | 3 | -$0.24 | -$0.19 | -$0.22 |
| Q1 2025 | 2 | -$0.24 | -$0.24 | -$0.24 |
| Q2 2025 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q3 2025 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q4 2025 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q1 2028 | 1 | $0.00 | $0.00 | $0.00 |
| Q2 2028 | 1 | $0.00 | $0.00 | $0.00 |
| Q3 2028 | 1 | $0.00 | $0.00 | $0.00 |
| Q4 2028 | 1 | $0.00 | $0.00 | $0.00 |
Reviva Pharmaceuticals Holdings, Inc. Earnings Date And Information
Reviva Pharmaceuticals Holdings, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.25 earnings per share for the quarter, missing analysts' consensus estimates of $-0.23 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Reviva Pharmaceuticals Holdings, Inc. has generated $-1 earnings per share over the last year ($-1.25 diluted earnings per share) and currently has a price-to-earnings ratio of -1.3. Reviva Pharmaceuticals Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 24th, 2025 based on prior year's report dates.
Reviva Pharmaceuticals Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/29/2023 | Q3 2023 | -$0.44 | $0 | $0 | ||
| 08/14/2023 | Q2 2023 | -$0.29 | -$0.55 | -0.26 | $0 | |
| 05/15/2023 | Q1 2023 | -$0.36 | -$0.30 | 0.06 | $0 | |
| 03/30/2023 | Q4 2022 | -$0.23 | -$0.42 | -0.19 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.30 | -$0.18 | 0.12 | $0 | |
| 08/15/2022 | Q2 2022 | -$0.31 | -$0.29 | 0.02 | $0 | |
| 05/16/2022 | Q1 2022 | -$0.28 | -$0.40 | -0.12 | $0 | |
| 03/15/2022 | Q4 2021 | -$0.24 | -$0.29 | -0.05 | $0 | |
| 11/15/2021 | Q3 2021 | -$0.25 | -$0.12 | 0.13 | $0 | |
| 08/16/2021 | Q2 2021 | -$0.24 | -$0.12 | 0.12 | $0 | |
| 05/17/2021 | Q1 2021 | -$0.10 | $0 | |||
| 03/22/2021 | Q4 2020 | -$0.06 | -$0.17 | -0.11 | $0 | |
| 10/14/2020 | Q3 2020 | -$0.24 | $0 | |||
| 07/07/2020 | Q2 2020 | -$0.31 | $0 | |||
| 05/01/2020 | Q1 2020 | -$0.27 | $0 | |||
| 01/10/2020 | Q4 2019 | $0.05 | $0 | |||
| 10/08/2019 | Q3 2019 | $0.11 | $0 | |||
| 07/03/2019 | Q2 2019 | $0.13 | $0 | |||
| 01/09/2019 | Q4 2018 | $0.10 | $0 | |||
| 10/11/2018 | Q3 2018 | $0.01 | $0 |
Reviva Pharmaceuticals Holdings, Inc. Earnings: Frequently Asked Questions
-
When is Reviva Pharmaceuticals Holdings, Inc.'s earnings date?
Reviva Pharmaceuticals Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 24th, 2025 based off last year's report dates.
-
How can I listen to Reviva Pharmaceuticals Holdings, Inc.'s earnings conference call?
The conference call for Reviva Pharmaceuticals Holdings, Inc.'s latest earnings report can be listened to online.
-
How can I read Reviva Pharmaceuticals Holdings, Inc.'s conference call transcript?
The conference call transcript for Reviva Pharmaceuticals Holdings, Inc.'s latest earnings report can be read online.
-
How much profit does Reviva Pharmaceuticals Holdings, Inc. generate each year?
Reviva Pharmaceuticals Holdings, Inc. (:RVPH) has a recorded net income of $0. Reviva Pharmaceuticals Holdings, Inc. has generated $-1.25 earnings per share over the last four quarters.
-
What is Reviva Pharmaceuticals Holdings, Inc.'s price-to-earnings ratio?
Reviva Pharmaceuticals Holdings, Inc. (:RVPH) has a price-to-earnings ratio of -1.3 and price/earnings-to-growth ratio is 0.07.
